{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:39:32Z","timestamp":1780670372063,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Fund Kenya"},{"DOI":"10.13039\/501100002222","name":"The World Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-018-2302-9","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:50:46Z","timestamp":1522799446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-2037","authenticated-orcid":false,"given":"Joseph O.","family":"Muga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah W.","family":"Gathirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matshawandile","family":"Tukulula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter G. Z. O.","family":"Jura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"2302_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","volume":"59","author":"AA Date","year":"2007","unstructured":"Date AA, Joshi MD, Patravale VB. Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev. 2007;59:505\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"2302_CR2","volume-title":"World malaria report 2016","author":"WHO","year":"2016","unstructured":"WHO. World malaria report 2016. Geneva: World Health Organization; 2016."},{"key":"2302_CR3","doi-asserted-by":"publisher","first-page":"1413266","DOI":"10.1080\/16549716.2017.1413266","volume":"10","author":"JK Maina","year":"2017","unstructured":"Maina JK, Macharia PM, Ouma PO, Snow RW, Okiro EA. Coverage of routine reporting on malaria parasitological testing in Kenya, 2015\u20132016. Global Health Action. 2017;10:1413266.","journal-title":"Global Health Action"},{"key":"2302_CR4","volume-title":"Kenya Malaria Operational Plan FY","author":"USAID","year":"2016","unstructured":"USAID, President\u2019s Malaria Initiative. Kenya Malaria Operational Plan FY. Washington, D.C.: USAID; 2016."},{"key":"2302_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1475-2875-13-405","volume":"13","author":"YA Afrane","year":"2014","unstructured":"Afrane YA, Zhou G, Githeko AK, Yan G. Clinical malaria case definition and malaria attributable fraction in the highlands of western Kenya. Malar J. 2014;13:405.","journal-title":"Malar J"},{"key":"2302_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"NS Santos-Magalh\u00e3es","year":"2010","unstructured":"Santos-Magalh\u00e3es NS, Mosqueira VCF. Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev. 2010;62:560\u201375.","journal-title":"Adv Drug Deliv Rev"},{"key":"2302_CR7","volume-title":"World malaria report 2014","author":"WHO","year":"2014","unstructured":"WHO. World malaria report 2014. Geneva: World Health Organization; 2014."},{"key":"2302_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","volume":"12","author":"GM Nayyar","year":"2012","unstructured":"Nayyar GM, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488\u201396.","journal-title":"Lancet Infect Dis"},{"key":"2302_CR9","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1111\/j.1742-4658.2007.05999.x","volume":"274","author":"JE Hyde","year":"2007","unstructured":"Hyde JE. Drug-resistant malaria\u2014an insight. FEBS J. 2007;274:4688\u201398.","journal-title":"FEBS J"},{"key":"2302_CR10","volume-title":"World malaria report 2017","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization; 2017."},{"key":"2302_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH Jong De","year":"2008","unstructured":"De Jong WH, Borm PJ. Drug delivery and nanoparticles: application and hazards. Int J Nanomed. 2008;3:133\u201349.","journal-title":"Int J Nanomed"},{"key":"2302_CR12","first-page":"221","volume-title":"Nanocrystalline materials: their application-structure-property relationships and application","author":"L Yan","year":"2013","unstructured":"Yan L, Chen X. Nanometerial for drug delivery. In: Tjong S-C, editor. Nanocrystalline materials: their application-structure-property relationships and application. Hong Kong: Elsevier; 2013. p. 221\u201368."},{"key":"2302_CR13","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1002\/adma.201305683","volume":"26","author":"Y Yan","year":"2014","unstructured":"Yan Y, Yang Y, Zhang W, Chen X. Advanced materials and nanotechnology for drug delivery. Adv Mater. 2014;26:5533\u201340.","journal-title":"Adv Mater"},{"key":"2302_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","volume":"86","author":"R Singh","year":"2009","unstructured":"Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Phathol. 2009;86:215\u201323.","journal-title":"Exp Mol Phathol"},{"key":"2302_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2174\/09298673113206660292","volume":"21","author":"P Urb\u00e1n","year":"2014","unstructured":"Urb\u00e1n P, Fern\u00e0ndez-Busquets X. Nanomedicine against malaria. Curr Med Chem. 2014;21:605\u201329.","journal-title":"Curr Med Chem"},{"key":"2302_CR16","doi-asserted-by":"publisher","first-page":"24368","DOI":"10.1038\/srep24368","volume":"6","author":"J Marques","year":"2016","unstructured":"Marques J, Vilanova E, Mour\u00e3o PAS, Fern\u00e0ndez-Busquets X. Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium. Sci Rep. 2016;6:24368.","journal-title":"Sci Rep"},{"key":"2302_CR17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","volume":"10","author":"J Marques","year":"2014","unstructured":"Marques J, Moles E, Urb\u00e1n P, Prohens R, Busquets MA, Sevrin C, et al. Application of heparin as dual agent with antimalarial and liposome targeting activties towards Plasmodium-infected red blood cells. Nanomedicine. 2014;10:1719\u201328.","journal-title":"Nanomedicine"},{"key":"2302_CR18","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2217\/nnm-2017-0127","volume":"12","author":"CR Al\u00e1ez-Vers\u00f3n","year":"2017","unstructured":"Al\u00e1ez-Vers\u00f3n CR, Lantero E, Fern\u00e0ndez-Busquets X. Heparin: new life for an old drug. Nanomedicine. 2017;12:1719\u201328.","journal-title":"Nanomedicine"},{"key":"2302_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0024-3205(97)01175-2","volume":"62","author":"C Passirani","year":"1998","unstructured":"Passirani C, Barrat G, Devissaguet JP, Labarre D. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci. 1998;62:775\u201385.","journal-title":"Life Sci"},{"key":"2302_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Frontiers Pharmacol. 2015;6:286.","journal-title":"Frontiers Pharmacol"},{"key":"2302_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1021\/nl052455y","volume":"6","author":"L Zhang","year":"2006","unstructured":"Zhang L, Granick S. How to stabilize phospholipid liposomes (Using nanoparticles). Nano Lett. 2006;6:694\u20138.","journal-title":"Nano Lett"},{"key":"2302_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.nano.2015.11.017","volume":"12","author":"WN Omwoyo","year":"2016","unstructured":"Omwoyo WN, Melariri P, Gathirwa JW, Olo F, Mahanga GM, Kalombo L, et al. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles. Nanomedicine. 2016;12:801\u20139.","journal-title":"Nanomedicine"},{"key":"2302_CR23","first-page":"3865","volume":"9","author":"WN Omwoyo","year":"2014","unstructured":"Omwoyo WN, Ogutu B, Olo F, Swai H, Kalombo L, Melariri P, Mahanga GM, et al. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles. Int J Nanomedicine. 2014;9:3865\u201374.","journal-title":"Int J Nanomedicine"},{"key":"2302_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12936-015-0570-1","volume":"14","author":"TA Miranda","year":"2015","unstructured":"Miranda TA, Silva PHR, Pianetti GA, C\u00e9sar IC. Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with HPLC-DAD method. Malar J. 2015;14:29.","journal-title":"Malar J"},{"key":"2302_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135.","journal-title":"Science"},{"key":"2302_CR26","volume-title":"Methods in malaria research","author":"K Moll","year":"2013","unstructured":"Moll K, Ljungstr\u00f6m I, Perlmann H, Scherf A, Wahlgren M. Methods in malaria research. 6th ed. Glasgow: EVIMalaR; 2013.","edition":"6"},{"key":"2302_CR27","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2302_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4269\/ajtmh.1984.33.772","volume":"33","author":"DG Sixsmith","year":"1984","unstructured":"Sixsmith DG, Watkins WM, Chulay JD, Spencer HC. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors. Am J Trop Med Hyg. 1984;33:772\u20136.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-018-2302-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T19:39:15Z","timestamp":1554147555000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-018-2302-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1186\/s12936-018-2302-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"13 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"133"}}